More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.0 Score)

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 1.25 --0 (-0%)
Prev. Close $1.25  
Open$1.23 
52 Wk High$ 
52 Wk Low$ 
Day High$1.26 
Day Low$1.16 
P/E N/A  
EPS$ 
Volume8,404,825 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

Oct 23, 2026 04:48 PM Form 4 Allogene Therapeutics, For: Oct 21 Filed by: Parker Geoffrey M.
Oct 21, 2026 07:48 PM Form 144 Allogene Therapeutics, Filed by: Parker Geoffrey M.
Sep 30, 2026 04:19 PM Form SCHEDULE 13D/A Allogene Therapeutics, Filed by: TPG GP A, LLC
Sep 15, 2026 05:29 AM Allogene (ALLO) Reiterated at Market Outperform by Citizens on Progress in Autoimmune Diseases
Sep 11, 2026 10:11 AM Form 8-K Allogene Therapeutics, For: Aug 31
Sep 2, 2026 08:30 AM Allogene Therapeutics CFO Geoffrey Parker to retire in November
Sep 2, 2026 08:30 AM Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker 
Aug 31, 2026 08:30 AM Allogene Therapeutics Announces Participation in September Investor Conference
Aug 25, 2026 04:43 PM Form 4 Allogene Therapeutics, For: Aug 21 Filed by: Douglas Earl Martin
Aug 21, 2026 07:27 PM Form 144 Allogene Therapeutics, Filed by: Douglas Earl Martin
View All Articles

Entities mentioned with ALLO

View All Entities